Table 1.
Number of Specimens | Mean Score (SDa) | pb | ||
Sex | ||||
Male | 57 | 7.5 (2.6) | p = 0.47 | |
Female | 25 | 7.9 (2.8) | ||
Age | ||||
< 30 | 22 | 9.0 (2.4) | p = 0.004 | |
≥ 30 | 60 | 7.1 (2.6) | ||
Histological typec | ||||
SCC | 1 | 7.1 (3.1) | p = 0.42 | |
NKC | 52 | 8.0 (2.3) | ||
UC | 29 | 7.6 (2.7) | ||
TNMd | ||||
T2 + T3 | 40 | 7.2 (2.6) | p = 0.18 | |
T4 | 42 | 8.0 (2.7) | ||
N0 | 21 | 7.4 (2.9) | p = 0.67 | |
N+ | 61 | 7.7 (2.6) | ||
M0 | 73 | 7.8 (2.5) | p = 0.83 | |
M+ | 9 | 7.6 (2.7) | ||
Metastatic relapse | ||||
+ | 24 | 7.5 (2.8) | p = 0.94 | |
- | 47 | 7.6 (2.6) | ||
NAe | 11 |
a SD: standard deviation b Based on the Student t-test cHistological type : SCC : squamous cell carcinoma, NKC : non-keratinizing carcinoma, UC : undifferentiated carcinoma. d Clinical staging: primary tumor extension classified T2, T3 or T4 according to AJCC/UICC (1997); regional lymph node extension classified N0 in the absence of clinical or radiological evidence of lymph node invasion at the initial workup, N+ in the other cases; metastatic status defined as M0 in the absence of clinical or radiological evidence of distant metastasis at the initial workup, M+ in the other cases (synchronous metastases). eNA : not applicable.